solution by MARKET

GMP-Compliant Pharmaceutical Equipment & Turnkey Solutions for Uganda

With a proven track record of delivering pharmaceutical turnkey plants in Uganda — endorsed by the nation’s highest leadership — IVEN is your trusted partner for building world-class production facilities in East Africa.

Market Overview

A Clear View of the Local Market Landscape

Uganda’s pharmaceutical market revenue reached an estimated US$346 million in 2024, with growth projected at an annual rate of 9.25%. Approximately 90% of medicines are imported from countries such as India and China, creating massive demand for local manufacturing infrastructure. The Ugandan government’s “Buy Uganda Build Uganda” policy actively promotes local pharmaceutical production, making now the ideal time to invest in GMP-compliant manufacturing capacity.

Market Demand

Demand Trends Within the Country

  • Local Production Infrastructure

    Challenges include limited access to affordable technology, machinery, and skilled expertise — Ugandan manufacturers urgently need turnkey partners who supply complete, production-ready solutions.
  • WHO GMP-Compliant Facilities

    Manufacturers inspected for GMP compliance must follow WHO GMP guidelines — all new plants require equipment built to international standards from the outset.
  • IV Solution & Essential Medicine Production

    The EAC targets at least five companies producing advanced formulations including small volume injectables, driving demand for sterile filling and IV production lines.
  • Regional Market Access

    “When you look at Uganda, you aren’t just looking at Uganda’s domestic market — you are looking at an integrated market in East Africa and beyond.”

Our Local Expertise

Local Experience, Reliable Execution

  • The President of Uganda visited IVEN Pharmatech’s new modern pharmaceutical factory in Uganda and expressed high appreciation — a milestone endorsement of our commitment to this market.

  • We’ve delivered turnkey projects in USA, Uzbekistan, Tajikistan, Indonesia, Thailand, Saudi Arabia, Iraq, Nigeria, Uganda, Laos, and more — with 40+ turnkey projects and 2,500+ production lines worldwide.

  • Our Uganda facility will produce drugs that meet international standards to meet the medical needs of the local and surrounding areas, supported by technical training and industrial cooperation.

  • 60+ proprietary technology patents with full in-house manufacturing across four owned factories — covering filling lines, water treatment systems, and intelligent logistics.

Recommended Products

Selected Products for This Market

Compliance & Logistics

Meeting Local Standards with Reliable Delivery

Compliance & Certification

  • All equipment complies with EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP — fully aligned with SFDA GMP inspection requirements

  • Complete IQ/OQ/PQ validation documentation packages provided for streamlined SFDA facility approval and GMP licensing

  • Engineering designs support Vision 2030 localization targets and NUPCO guaranteed offtake procurement eligibility

Logistics & Delivery

  • Direct shipping from four owned manufacturing bases in China to Mombasa Port (Kenya), with overland transit to Kampala.

  • Dedicated engineering teams deployed on-site for installation, commissioning, operator training, and full validation support.

  • Flexible payment terms including L/C and T/T — compatible with government procurement and private-sector investment structures.

case

Success Snapshot

  • Pharmaceutical Manufacturer

    Uganda

    The President’s visit marked a new stage of cooperation between IVEN and Uganda, with the pharmaceutical factory set to usher in broader development prospects and set a new benchmark for the health industry in Africa. The facility is designed to produce medicines meeting international standards for the local and regional East African market.

  • Healthcare Enterprise

    West Africa

    IVEN delivered a complete Soft Bag IV Solution turnkey plant in Nigeria capable of producing 20 million soft bags per year. IVEN continues constructing high-class pharmaceutical factories in Africa so that local people can benefit from safe pharmaceutical products of home manufacture.

testimony

Trusted by Local Customers

  • “IVEN delivered a fully equipped pharmaceutical plant that met WHO GMP standards and was ready for NDA inspection. Their on-site team provided thorough training and stayed until our production line was fully operational.”

    Mr. A

    Managing Director

  • “From project design through commissioning, IVEN demonstrated deep understanding of East African regulatory requirements and logistics. They are a true partner for local pharmaceutical manufacturing.”

    Mr. B

    CEO

Support

FAQ

Yes. The President of Uganda recently visited IVEN’s new modern pharmaceutical factory in the country. Uganda is a key strategic market where we have delivered turnkey plant solutions.

All equipment is built to WHO GMP standards — the same guidelines Uganda’s NDA requires manufacturers to follow for GMP compliance inspections.

Yes. Our equipment and documentation are designed for EAC MRH compatibility, enabling product registration across Uganda, Kenya, Tanzania, Rwanda, and other EAC member states.

We ship directly from our factories in China to Mombasa Port, then overland to Kampala. Our project team manages logistics end-to-end, including customs clearance coordination.

We provide remote diagnostics, spare parts supply, operator retraining, and on-site technical support as needed — ensuring long-term production continuity.

Related Market Solutions